Literature DB >> 25703702

The spectrum of MEFV gene mutations and genotypes in Van province, the eastern region of Turkey, and report of a novel mutation (R361T).

Salih Coşkun1, Lokman Ustyol2, Yasemin Bayram3, M Selçuk Bektaş4, Suleyman Gulsen4, Abdullah Çim5, Unal Uluca6, Didem Savaş7.   

Abstract

Familial Mediterranean fever (FMF) is the most common hereditary inflammatory periodic disease, characterized by recurrent episodes of fever and abdominal pain, synovitis, and pleuritis. The aim of this study was to determine the frequency and distribution of Mediterranean fever (MEFV) gene mutations in Van province of Eastern Anatolia and to compare them with the other studies from various regions of Turkey. Therefore, we retrospectively evaluated MEFV gene mutations in 1058 pediatric patients with suspected FMF. The MEFV gene mutations were investigated using Sanger sequencing and the multiplex minisequencing technique. We identified 37 different genotypes and 16 different mutations. The four most common mutations and allelic frequencies were M694V (36.50%), E148Q (32.77%), V726A (14.09%), and M694I (4.41%). M694V was the most common mutation, and the M694I frequency was found to be higher compared to studies from other regions of Turkey. In addition, we identified a novel missense mutation (R361T, c.1082G>C) in exon 3 of the MEFV gene in a 12-year-old boy, who had a typical FMF phenotype. In conclusion, this study evaluated the distribution of MEFV gene mutations in children with FMF as the first study conducted in Van province, Eastern Anatolia.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allelic frequencies; Familial Mediterranean fever; MEFV; Novel mutation; R361T; c.1082G>C

Mesh:

Substances:

Year:  2015        PMID: 25703702     DOI: 10.1016/j.gene.2015.02.059

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Frequency of mutations in Mediterranean fever gene, with gender and genotype-phenotype correlations in a Turkish population.

Authors:  Salih Coşkun; Serkan Kurtgöz; Ece Keskin; Ferah Sönmez; Gökay Bozkurt
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

2.  The Spectrum of MEFV Gene Mutations and Genotypes in the Middle Northern Region of Turkey.

Authors:  Gokce Celep; Zeynep Hulya Durmaz; Yalciner Erdogan; Seviye Akpinar; Saban Abdullah Kaya; Rıdvan Guckan
Journal:  Eurasian J Med       Date:  2019-10

3.  The Frequency of MEFV Gene Mutations and Genotypes in Sanliurfa Province, South-Eastern Region of Turkey, after the Syrian Civil War by Using Next Generation Sequencing and Report of a Novel Exon 4 Mutation (I423T).

Authors:  Evren Gumus
Journal:  J Clin Med       Date:  2018-05-07       Impact factor: 4.241

4.  Prevalence of MEFV gene mutations in a large cohort of patients with suspected familial Mediterranean fever in Central Anatolia.

Authors:  Malik Ejder Yildirim; Hande Kucuk Kurtulgan; Ozturk Ozdemir; Hasan Kilicgun; Didem S Aydemir; Burak Baser; Ilhan Sezgin
Journal:  Ann Saudi Med       Date:  2019-12-05       Impact factor: 1.526

5.  Presentation of a new mutation in FMF and evaluating the frequency of distribution of the MEFV gene mutation in our region with clinical findings.

Authors:  Abdullah Arpacı; Serdar Doğan; Hazal Fatma Erdoğan; Çiğdem El; Sibel Elmacıoğlu Cura
Journal:  Mol Biol Rep       Date:  2021-03-18       Impact factor: 2.316

6.  Correlation genotype-phenotype: MEFV gene mutations and Moroccan patients with rheumatoid arthritis.

Authors:  Hakima Missoum; Najlae Adadi; Mohammed Alami; Hamza Toufik; Abdelhakim Bouyahya; Fatima-Zahra Laarabi; Fatima Bachir; Abdellah El Maghraoui; Youssef Bakri
Journal:  Pan Afr Med J       Date:  2022-02-11

7.  Association between sequence variations of the Mediterranean fever gene and the risk of migraine: a case-control study.

Authors:  Salih Coşkun; Sefer Varol; Hasan H Özdemir; Sercan Bulut Çelik; Metin Balduz; Mehmet Akif Camkurt; Abdullah Çim; Demet Arslan; Mehmet Uğur Çevik
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-29       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.